UK victim of Mumbai attacks to sue owners of Taj Mahal hotel

November 27, 2013

Mumbai_attacksLondon, Nov 27: A 33-year-old British man, paralysed during the Mumbai terror attacks in November 2008, is suing the owners of the iconic Taj Mahal Palace Hotel, alleging they did little to provide security for guests despite several warnings that an assault on the hotel was imminent.

Will Pike from North London is taking legal action against the Indian Hotels Company Ltd, a part of the Tata Group.

Pike will approach the High Court in London on December 2 to argue against an attempt by the hotel owners to prevent his legal case against them being heard in a UK court, his lawyers said on the fifth anniversary of the terrorist assault on India's financial hub that left 166 people dead.

Pike was paralysed when he fell nearly 50 feet breaking his back, pelvis and leg and fracturing both his left wrist and right elbow in a bid to escape the LeT terrorists as they went through the hotel shooting residents and setting fires.

Leigh Day, his London-based lawyers are bringing a civil claim for damages against the Indian Hotels Company.

They allege the owners of the hotel did little to provide security for residents despite several warnings that an attack on the hotel was imminent.

They argue that the case should be heard in the UK, where Pike lives and where the Indian Hotels Company has a substantial business presence, based around the Crowne Plaza St James Hotel and the Taj Suites, just a stone's throw from Buckingham Palace in London.

Trying to fight the Tatas, India's largest corporate group, through the Indian courts is an exercise in futility according to Pike's lawyer, Russell Levy.

Levy said, "Mr Pike's only real hope of seeing justice is in a UK court. The court in Mumbai simply isn't geared up to deal with a claim of this kind. We estimate that it would take up to 25 years to pursue this claim through the Indian courts rather than in England, where it will take about two years.

"It is simply not right that this billion-dollar corporate giant wants to drag our wheelchair-bound client back to India and take him through a legal system where the inequality of arms would be significant," he said.

Pike and his girlfriend at that time, Kelly Doyle, who is also represented by Leigh Day, checked into the Taj Mahal Palace Hotel on November 26, 2008.

While escaping through a hotel window, the knots in the bedding cloth he used as a rope came undone and Pike fell to the ground suffering serious injuries though Doyle was saved.

Pike, who is now confined to a wheelchair, said, "My aim in taking this legal action is to pay for the life long care I now need...I do not see why the British taxpayer should have to pay for the life long care I need rather than those who I believe did not do enough to guarantee my safety and the safety of all those caught up in this atrocity."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 29,2020

Bengaluru, May 29: Former prime minister H D Deve Gowda mourned the demise of Rajya Sabha member and Managing Director of leading Malayalam daily Mathrubhumi M P Veerendra Kumar, hailing him as a great journalist and writer.

"My deepest condolences on the demise of former union Minister and Rajya sabha member Shri M.P. Veerendra Kumar. He was a great journalist and writer. May god give strength to his family & his people to bear the loss," Gowda said in his condolence message.

Veerandra Kumar, who was a member of PTIs Board of Directors, died late Thursday at a private hospital in Kozhikode in Kerala following cardiac arrest.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 4,2020

New Delhi, Jan 4: In more troubles for the former Finance Minister and senior Congress leader P Chidambaram, the Enforcement Directorate (ED) on Friday questioned him for over six hours in its probe into the Air India aircraft deal case, first time since his release from Tihar jail almost a month ago.

A senior ED official told IANS, "We questioned Chidambaram for over six hours today in the ongoing probe into the Air India deal with Airbus."

According to financial probe agency officials, Air India had planned to buy over 111 aircraft from Airbus and Boeing during the erstwhile United Progressive Alliance (UPA) government in 2009. This is the first time the ED has questioned the senior Congress leader in the Air India deal case.

The questioning of Chidambaram came for the first time since his release from the Tihar jail where he spent 106 days in connection with the INX Media money laundering case. He was released from Tihar on December 4 last year after he was granted bail by the Supreme Court. The former finance minister is also being investigated by the ED in a separate money-laundering cases of Aircel-Maxis deal.

An ED official said the contract to buy 43 aircraft from Airbus was finalised by a panel of ministers headed by Chidambaram in 2009. According to the ED, when the proposal to buy 43 aircraft from Airbus was sent to the Cabinet Committee on Security (CCS), there was a condition that the aircraft manufacturer would have to build training facilities and MRO (Maintenance, Repair and Overhaul) centres at a cost of Rs 70,000 crore. But later, when the purchase order was placed, the clause was removed.

The name of another UPA minister, Praful Patel, had also come up in the alleged scam in a charge sheet filed by the ED against corporate lobbyist Deepak Talwar on March 30 last year. Talwar was arrested last year by the ED after he was deported from the UAE.

The ED is probing the Air India-Indian Airlines merger; purchase of 111 aircraft from Boeing and Airbus at Rs 70,000 crore; ceding profitable routes and schedules to private airlines, and opening of training institutes with foreign investment.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.